These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4393695)

  • 1. [Value of "LB-125" in the treatment of emotional and behavior disorders in young children].
    Combes-Hamelle A; Stelian Y
    Therapeutique; 1970; 46(6):665-6. PubMed ID: 4393695
    [No Abstract]   [Full Text] [Related]  

  • 2. [Deadyn: treatment of behavior disorders].
    Dall'Oglio GN
    Riv Sper Freniatr Med Leg Alien Ment; 1967 Apr; 91(2):576-82. PubMed ID: 4384083
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of magnesium bromoglutamate syrup for problems of behavior and psychomotor development of the child].
    Combes-Hamelle A; Stelian Y
    Ann Pediatr (Paris); 1968; 15(8):585-6. PubMed ID: 5685048
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experimetation with Piracetam].
    Dubois B; Fontaine G
    Lille Med; 1973; 18(7):832-5. PubMed ID: 4152650
    [No Abstract]   [Full Text] [Related]  

  • 5. What's to be done with "bad" children?
    Nelson R
    Iowa Med; 1996; 86(9):373. PubMed ID: 8961633
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects and side effect in the treatment of children with stimulants (author's transl)].
    Klicpera C
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jul; 46(7):392-414. PubMed ID: 27439
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy with psychotropic drugs in children and adolescents].
    Strunk P
    Internist (Berl); 1972 May; 13(5):197-200. PubMed ID: 4403072
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of psycho-active drugs in children.
    Werry JS
    IMJ Ill Med J; 1967 Jun; 131(6):785-7 passim. PubMed ID: 4382895
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of amitryptyline drops, in ambulatory therapy, on behavior and character disorders in children and adolescents].
    Sallou C
    Rev Neuropsychiatr Infant; 1969 Dec; 17(12):859-64. PubMed ID: 5369060
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations about the use of psychopharmaca in child psychiatry.
    van Krevelen DA
    Acta Paedopsychiatr; 1971; 38(2):47-59. PubMed ID: 4399609
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of pimozide in child psychiatry].
    Debray P; Messerschmitt P; Lonchamp D; Herbault M
    Nouv Presse Med; 1972 Dec; 1(43):2917-8. PubMed ID: 4119351
    [No Abstract]   [Full Text] [Related]  

  • 12. [What can we expect from a psychoanaleptic agent for facilitating orthophonic and psychomotor rehabilitation?].
    Gueriot C; Dugas M
    Therapeutique; 1972 Dec; 48(10):667-9. PubMed ID: 4661292
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychopharmacologic treatment of aggressive preschoolers: a chart review.
    Staller JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):131-5. PubMed ID: 17007977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of oxaflumazine acid disuccinate in the treatment of 24 cases of psychotic children in a pedopsychiatric environment].
    Sichel JP; Poupier G
    Rev Neuropsychiatr Infant; 1972; 20(3):367-74. PubMed ID: 5055026
    [No Abstract]   [Full Text] [Related]  

  • 16. The hyperactive child: who is he?
    Woodard PB; Brodie B
    Nurs Clin North Am; 1974 Dec; 9(4):727-45. PubMed ID: 4153794
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy program for children with hyperkinetic and oppositional problem behavior--organization and single case evaluation].
    Döpfner M; Lehmkuhl G; Schürmann S
    Z Kinder Jugendpsychiatr Psychother; 1996 Sep; 24(3):145-63. PubMed ID: 9459672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs for problem school children.
    Safer DJ
    J Sch Health; 1971 Nov; 41(9):491-5. PubMed ID: 4399004
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psychopharmacological drugs in childhood (author's transl)].
    Groh C; Rosenmayr F
    Padiatr Padol; 1982; 17(2):319-28. PubMed ID: 7099685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental attitudes and involvement in psychopharmacological treatment for ADHD: a conceptual model.
    dosReis S; Myers MA
    Int Rev Psychiatry; 2008 Apr; 20(2):135-41. PubMed ID: 18386203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.